Bio Port Korea바이오포트

Bio Port Korea returned to a small TTM operating profit on revenue of about ₩78B, while its share price has fallen roughly 49% over the past year.

Bio Port Korea makes snacks, liquid teas and drinks, including private-label products for large retail chains such as Costco and GS Retail. Trailing twelve-month data to H1 2026 shows revenue of ₩78.0B, operating income of ₩2.4B and net income of ₩3.0B, after a loss-making 2025. The company is also expanding production capacity 2.3x and has bought a further stake in Family Farm, though free cash flow was negative over the period.

What stands out

• TTM operating margin is 3.1% and net margin is 3.8%, versus 1.2% and a net loss in 2025 and 7.1% operating margin in 2024.
• Free cash flow was about -₩6.3B over the trailing period, while cash of ₩18.0B sits against borrowings of ₩15.7B.
• Shares closed at ₩5,070 on 2026-10-27, up 15.1% over three months but down 49.4% over one year, within a 52-week range of ₩4,000 to ₩10,200.
• The company's DCF-based fair value model gives a base of ₩6,749, with bear and bull cases of ₩2,468 and ₩14,569; these are model outputs, not forecasts.
• Recent filings include an acquisition of shares in another company (2026-10-16) and the half-year report, and news coverage focuses on Family Farm expansion and overseas targets.

What to watch

• Whether the 2.3x capacity expansion and North America push translate into sustained revenue growth, since 2025 revenue fell 3.4%.
• Cash flow and debt: negative free cash flow alongside ₩15.7B of borrowings, with liabilities at 56% of equity.
• Upcoming results and filings, as the data does not include a forward earnings calendar; the investor-flow data shows foreign ownership falling from 3.3% to 2.4% over 60 days.